Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
12/09/2023 13:26
Sept 12 (Reuters) - Paratek Pharmaceuticals Inc
PRTK.O :
* SECOND LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS
RECOMMENDS PARATEK PHARMACEUTICALS STOCKHOLDERS VOTE FOR THE
ACQUISITION BY GURNET POINT CAPITAL AND NOVO HOLDINGS A/S
Source text for Eikon: ID:nGNX4NNjyn
Further company coverage: PRTK.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million